137 related articles for article (PubMed ID: 37770377)
41. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
Chandrasekaran PK
Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
[TBL] [Abstract][Full Text] [Related]
42. Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.
Nystazaki M; Alevizopoulos G
Psychiatriki; 2021 Jul; 32(2):165-166. PubMed ID: 33759812
[TBL] [Abstract][Full Text] [Related]
43. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
44. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
45. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
46. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
47. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
[TBL] [Abstract][Full Text] [Related]
48. Clozapine induced agranulocytosis: hypothesis on immune-mediated pathogenesis and the role of haematopoietic growth factors.
Faber HJ; Smit AJ; van de Loosdrecht AA
Neth J Med; 1999 Aug; 55(2):86-7. PubMed ID: 10474279
[No Abstract] [Full Text] [Related]
49. Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.
Lahdelma L; Appelberg B
J Clin Psychiatry; 2012 Jun; 73(6):837-42. PubMed ID: 22480452
[TBL] [Abstract][Full Text] [Related]
50. Increase in white cell and neutrophil counts during the first eighteen weeks of treatment with clozapine in patients admitted to a long-term psychiatric care inpatient unit.
Capllonch A; de Pablo S; de la Torre A; Morales I
Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(2):94-100. PubMed ID: 27156787
[TBL] [Abstract][Full Text] [Related]
51. Maximizing clozapine therapy: managing side effects.
Lieberman JA
J Clin Psychiatry; 1998; 59 Suppl 3():38-43. PubMed ID: 9541337
[TBL] [Abstract][Full Text] [Related]
52. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
53. A follow-up study of a population of schizophrenic patients treated with clozapine.
Bourin M; Guitton B; Dailly E; Hery P; Jolliet P
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1481-95. PubMed ID: 11642649
[TBL] [Abstract][Full Text] [Related]
54. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
55. What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database.
Laforgue EJ; Istvan M; Guerlais M; Chaslerie A; Artarit P; Vallot G; Jolliet P; Grall-Bronnec M; Victorri-Vigneau C
Expert Opin Drug Saf; 2021 Oct; 20(10):1247-1256. PubMed ID: 34085879
[TBL] [Abstract][Full Text] [Related]
56. Olanzapine: safe during clozapine-induced agranulocytosis.
Oyewumi LK; Al-Semaan Y
J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
[No Abstract] [Full Text] [Related]
57. [Clozapine].
Inada K; Ishigooka J
Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
[TBL] [Abstract][Full Text] [Related]
58. [Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up].
Pons A; Undurraga J; Batalla A; Bernardo M
Rev Psiquiatr Salud Ment; 2012; 5(1):37-42. PubMed ID: 22854502
[TBL] [Abstract][Full Text] [Related]
59. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
60. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
Martina AC; Ee JS; Lamberti JS
Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
